Insights

Insights

Filter by:
Governing Laws
Sector Life sciences & healthcare
Sub-sector
Service
Sub-service
Hot Topics Coronavirus
Pipette injecting liquid into microtiter plate on white background
Life sciences & healthcare

Will the UK government's COVID-19 dosing regime gamble pay off?

11 January 2021
Briefing

by Alison Dennis and Justyna Ostrowska

Click here to find out more
Coronavirus

Next Normal Legal ‒ The Legal Situation in Germany after Covid-19

8 December 2020

by Dr. Oliver Klöck

Click here to find out more
Androids and facial mapping
Technology, media & communications

Life sciences and healthcare predictions 2021: more politics

4 December 2020
Briefing

by Alison Dennis and Justyna Ostrowska

Click here to find out more
Data centre server room
Data protection & cyber

Global Data Hub - Health data

27 November 2020
Quick read

by multiple authors

Click here to find out more
healthcare
Life sciences & healthcare

Russian coronavirus vaccine – approval process in Hungary and the EU

Available in Hungarian

24 November 2020
Briefing

by Zoltán Novák, Ph.D.

Click here to find out more
Pipets
Patents & innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

23 November 2020
Quick read

by multiple authors

Click here to find out more
Scientist studying molecule model
Patents & innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

9 November 2020
Quick read

by multiple authors

Click here to find out more
Life sciences & healthcare

Return to work: key issues for life sciences

4 August 2020
QUICK READ

by Helen Farr and Adrian Toutoungi

Click here to find out more
pills
Coronavirus

Patent law in emergency situations

14 July 2020
QUICK READ

by David Mulder

Click here to find out more
server-room
Technology, media & communications

Future Fund: update to connected person test following Taylor Wessing (and others) request for changes

9 July 2020
QUICK READ

by multiple authors

Click here to find out more
scientist-with-molecule-models
Life sciences & healthcare

Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow

23 June 2020
IN-DEPTH ANALYSIS

by Adrian Toutoungi and Josef Fuss

Click here to find out more
scientist-with-vials
Life sciences & healthcare

Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues

22 June 2020
IN-DEPTH ANALYSIS

by Adrian Toutoungi and Josef Fuss

Click here to find out more